$ADVB
Advanced Biomed Inc.
Nasdaq · Healthcare · Services-Medical Laboratories · Reno, NV
ADVB chart
What traders are saying about $ADVB
Latest postsAdvanced Biomed Inc. news
- Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
Yahoo Finance ·
- Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
Yahoo Finance ·
- Advanced Biomed sells Hong Kong subsidiary for $23,000
Yahoo Finance ·
- Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
Yahoo Finance ·
Advanced Biomed Inc. key financials
| USD | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | $127,637 | – | – |
| Net income | $6.7M | -$3.3M | -$2.8M |
| Diluted EPS | $5.33 | $-3.18 | $-0.14 |
| Total assets (year end) | – | $10.9M | $4.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Advanced Biomed Inc.
- Ticker
- ADVB (Nasdaq)
- Industry
- Services-Medical Laboratories
- Headquarters
- Reno, NV
- Incorporated in
- NV
- Fiscal year end
- June 30
- SEC CIK
- 1941029
Frequently asked questions
What exchange is Advanced Biomed Inc. listed on?
Advanced Biomed Inc. trades on the Nasdaq under the ticker symbol ADVB.
What industry is Advanced Biomed Inc. in?
Advanced Biomed Inc. is classified by the SEC under "Services-Medical Laboratories", part of the Healthcare sector on StockTweeting.
Where is Advanced Biomed Inc. headquartered?
Advanced Biomed Inc.'s business address on file with the SEC is in Reno, NV.
When does Advanced Biomed Inc.'s fiscal year end?
Advanced Biomed Inc.'s fiscal year ends on June 30.
How much revenue did Advanced Biomed Inc. report?
Advanced Biomed Inc. reported $127,637 in revenue for calendar year 2026, according to its SEC filings.